Quantum Biopharma Stock Today
| QNTM Stock | 4.22 0.33 7.25% |
PerformanceInsignificant
| Odds Of DistressHigh
|
Quantum BioPharma is selling at 4.22 as of the 4th of March 2025; that is 7.25% down since the beginning of the trading day. The stock's lowest day price was 4.05. Quantum BioPharma has a very high chance of experiencing financial distress in the next few years of operation. It also did not have a very good performance during the last 90 trading days. Quantum BioPharma symbol was changed from HUGE on 15th of August 2024. The performance scores are derived for the period starting the 15th of March 2023 and ending today, the 4th of March 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | IPO Date 8th of June 2018 | Category Healthcare | Classification Health Care |
Quantum BioPharma is entity of United States. It is traded as Stock on NASDAQ exchange. The company has 1.55 M outstanding shares of which 328.5 K shares are at this time shorted by private and institutional investors with about 0.22 trading days to cover. More on Quantum BioPharma
Moving against Quantum Stock
Quantum Stock Highlights
| Older Symbol | HUGE | |||||||||||||||||||||||||||||||||||
| CEO, Founder | Zeeshan Saeed | |||||||||||||||||||||||||||||||||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Health Care, Health Care, Biotechnology, Drug Manufacturers - Specialty & Generic, Healthcare (View all Sectors) | |||||||||||||||||||||||||||||||||||
Financial Strength
| ||||||||||||||||||||||||||||||||||||
Quantum BioPharma (QNTM) is traded on NASDAQ Exchange in USA. It is located in 55 University Ave., Toronto, ON, Canada, M5J 2H7 and employs 10 people. Quantum BioPharma was previously known as HUGE Old and was traded on NASDAQ Exchange under the symbol HUGE. Quantum BioPharma is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 6.17 M. Quantum BioPharma conducts business under Biotechnology sector and is part of Health Care industry. The entity has 1.55 M outstanding shares of which 328.5 K shares are at this time shorted by private and institutional investors with about 0.22 trading days to cover.
Quantum BioPharma generates negative cash flow from operations
Check Quantum BioPharma Probability Of Bankruptcy
Ownership AllocationQuantum BioPharma holds 14.1 pct. of its outstanding shares held by insiders and 1.54 pct. owned by third-party entities.
Check Quantum Ownership Details
Quantum BioPharma Historical Income Statement
Quantum Stock Against Markets
Quantum BioPharma Corporate Management
| Kevin Cassidy | Vice QualityLucid | Profile | |
| Donal CPA | Chief Officer | Profile | |
| Jason Sawyer | Head Acquisitions | Profile | |
| Maryann Adesso | Corporate Secretary | Profile | |
| Nathan CPA | Chief Officer | Profile |
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Quantum BioPharma. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate. To learn how to invest in Quantum Stock, please use our How to Invest in Quantum BioPharma guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Quantum BioPharma. If investors know Quantum will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Quantum BioPharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Quantum BioPharma is measured differently than its book value, which is the value of Quantum that is recorded on the company's balance sheet. Investors also form their own opinion of Quantum BioPharma's value that differs from its market value or its book value, called intrinsic value, which is Quantum BioPharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Quantum BioPharma's market value can be influenced by many factors that don't directly affect Quantum BioPharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Quantum BioPharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Quantum BioPharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Quantum BioPharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.